Keith L Knutson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Keith L Knutson

Showing results (121-130 of 147) with videos related to

Pageof 15

Sort By:

Frontiers in Immunology|February 16, 2026

Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapyAndrew Liu, Brian Necela, Zhuo Li, et al.

Breast Cancer Research and Treatment|January 15, 2020

Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast diseaseSabina Adhikary, Tanya L Hoskin, Melody L Stallings-Mann, et al.

Cancer Immunology, Immunotherapy : CII|July 22, 2009

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigenLavakumar Karyampudi, Christopher J Krco, Kimberly R Kalli, et al.

BMC Cancer|June 9, 2009

Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancerKristin L White, Robert A Vierkant, Catherine M Phelan, et al.

Frontiers in Endocrinology|December 24, 2024

BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppressionAna-Maria Sigarteu Chindris, Michael Rivera, Yaohua Ma, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinomaSameer A Siddiqui, Xavier Frigola, Sandra Bonne-Annee, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2017

Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer DevelopmentAmy C Degnim, Tanya L Hoskin, Muhammad Arshad, et al.

Inflammatory Bowel Diseases|September 14, 2022

Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 VaccinationFreddy Caldera, Francis A Farraye, Brian M Necela, et al.

Cancer Research|November 16, 2014

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.

Nature Medicine|August 24, 2004

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalTyler J Curiel, George Coukos, Linhua Zou, et al.

Pageof 15

Search research articles

Showing results (121-130 of 147) with videos related to

Sort By:

Pageof 15

Frontiers in Immunology|February 16, 2026

Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapyAndrew Liu, Brian Necela, Zhuo Li, et al.

Breast Cancer Research and Treatment|January 15, 2020

Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast diseaseSabina Adhikary, Tanya L Hoskin, Melody L Stallings-Mann, et al.

Cancer Immunology, Immunotherapy : CII|July 22, 2009

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigenLavakumar Karyampudi, Christopher J Krco, Kimberly R Kalli, et al.

BMC Cancer|June 9, 2009

Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancerKristin L White, Robert A Vierkant, Catherine M Phelan, et al.

Frontiers in Endocrinology|December 24, 2024

BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppressionAna-Maria Sigarteu Chindris, Michael Rivera, Yaohua Ma, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinomaSameer A Siddiqui, Xavier Frigola, Sandra Bonne-Annee, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2017

Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer DevelopmentAmy C Degnim, Tanya L Hoskin, Muhammad Arshad, et al.

Inflammatory Bowel Diseases|September 14, 2022

Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 VaccinationFreddy Caldera, Francis A Farraye, Brian M Necela, et al.

Cancer Research|November 16, 2014

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.

Nature Medicine|August 24, 2004

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalTyler J Curiel, George Coukos, Linhua Zou, et al.

Pageof 15